<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41480-bib-0075">
 <label>75</label>
 <mixed-citation publication-type="book" id="hep41480-cit-0075">
  <collab collab-type="authors">ClinicalTrials.gov</collab> . 
  <source xml:lang="en">Study of the efficacy and safety of lonafarnib/ritonavir with and without pegylated interferon‐alfa‐2a (D‐LIVR)</source>. Identifier NCT03719313. 
  <publisher-loc>Bethesda, MD</publisher-loc>: 
  <publisher-name>National Library of Medicine (US)</publisher-name>; 
  <year>2019</year>
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03719313" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT03719313</ext-link>. Accessed December 15, 2019.
 </mixed-citation>
</ref>
